Vaccine Relief: The Race to the Finish Line
We have seen this week a second vaccine developer approach the FDA for Emergency Use Authorization (EUA) of a new vaccine for SARS-CoV2. The race to the starting line has a couple winners, although we expect that more vaccine candidates will reach the stage of FDA review as we go through the winter and into…